Provider Alert! Change in Preferred Drug List Status for Lincosamides/Oxazolidinones/Streptogramins Drug Class
Date: May 9, 2024 Attention: All Providers Effective date: May 7, 2024 Call to action: Effective May 7, 2024, the Texas Health and Human Services (HHS) removed non-preferred status from generic linezolid suspension products. This is in response to the long term back order of the brand product Zyvox by the manufacturer. The preferred status of the brand name Zyvox will not change to allow any current stock to be used. How this impacts providers: The change will allow providers to prescribe the generic without...